Ardent Health, Inc.
ARDTNYSECIK 1756655HealthcareFiscal year ends Dec 31
Reports and events: 40 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2316:42 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-118499 |
| 2026-09-0416:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-060735 |
| 2026-08-1016:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-055215 |
| 2026-08-0416:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052598 |
| 2026-06-3016:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-046247 |
| 2026-06-0216:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-253567 |
| 2026-05-2616:37 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-038152 |
| 2026-05-0616:19 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-031299 |
| 2026-05-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030552 |
| 2026-04-0816:17 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001628280-26-024244 |
| 2026-03-2716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-021738 |
| 2026-03-1616:13 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-018174 |
| 2026-03-0416:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-014640 |
| 2025-11-1816:14 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-052879 |
| 2025-11-1416:14 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-052362 |
| 2025-11-1216:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-051634 |
| 2025-09-2316:32 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-25-042486 |
| 2025-08-0616:37 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001756655-25-000018 |
| 2025-08-0516:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001756655-25-000013 |
| 2025-06-2016:48 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001756655-25-000009 |
| 2025-05-2316:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-027604 |
| 2025-05-0716:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-023210 |
| 2025-05-0616:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-022722 |
| 2025-04-0816:47 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001628280-25-017085 |
| 2025-04-0317:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-016620 |
| 2025-03-3116:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-015672 |
| 2025-02-2716:46 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-008727 |
| 2025-02-2616:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-008185 |
| 2025-01-1316:34 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-001368 |
| 2024-11-0716:32 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001756655-24-000017 |
| 2024-11-0617:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001756655-24-000010 |
| 2024-08-1417:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-037278 |
| 2024-08-1416:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-037235 |
| 2024-07-1506:05 ET | S-1/A | Registration statement, amended | 0001193125-24-178802 |
| 2024-07-1016:39 ET | S-1/A | Registration statement, amended | 0001193125-24-177285 |
| 2024-07-0817:31 ET | S-1/A | Registration statement, amended | 0001193125-24-176379 |
| 2024-06-2117:30 ET | S-1 | Registration statement | 0001193125-24-165883 |
| 2019-03-0616:36 ET | S-1/A | Registration statement, amended | 0001193125-19-065643 |
| 2018-12-2113:14 ET | S-1/A | Registration statement, amended | 0001193125-18-355936 |
| 2018-12-0415:56 ET | S-1 | Registration statement | 0001193125-18-342132 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.